ArticleMolecular cancer therapeutics2021

The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria.

Christopher W Schultz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.